H19 and non-small cell lung carcinoma: Another example, downregulating H19 has been shown to sensitize NSCLC cells to EGFR-TKI therapy, indicating a direct link between lncRNA expression and therapeutic response (Arun et al. 2018; Jiang et al. 2021).